CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs | Sheppard Mullin Richter & Hampton LLP

On February 9, 2023, the Centers for Medicare and Medicaid Services (“CMS”) released two highly-anticipated guidance documents (the “Guidance”) detailing the agency’s proposed...

Related Keywords

,Department Of Justice ,Partd Rebate Program ,Partb Rebate Program ,Rebate Program ,Sheppard Mullin Richter Hampton ,Centers For Medicare ,Supplementary Medical Insurance Trust Fund ,Public Health Service ,Drug Negotiation Program ,B Drug Pricing Program ,Medicaid Services ,Medicaid Drug Rebate Program ,Sheppard Mullin Richter ,Prescription Drug Inflation Rebate Programs ,Rebate Programs ,Inflation Reduction Act ,Affordable Care ,Key Guidance ,Social Security Act ,Medicare Prescription Drug Account ,Federal Supplementary Medical Insurance Trust ,Guidance Final ,Partd Rebate Programs ,Drug Pricing Program ,Medicare Advantage ,Partb Inflation Rebate ,Partd Inflation Rebate Comments ,Consumer Price Index ,Urban Consumers ,Emergency Use Authorization ,Healthcare Common Procedure Coding System ,Coinsurance Rates ,Key Dates ,Medicare Part ,Medicaid Drug Rebate ,Medicare Rebate ,Press Release ,Initial Guidance ,Public Health Service Act ,Security Act ,Partb Inflation Rebates ,Abbreviated New Drug Application ,Partd Inflation Rebates ,